Singapore markets closed

Altimmune, Inc. (3G0.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
5.99+0.56 (+10.33%)
At close: 05:32PM CEST
Show:
Balance sheet
Cash flow
Annual

Income statement

Currency in USD. All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
410
426
-68
4,410
8,185
-
Operating expenses
Research development
70,037
65,799
70,538
74,541
49,774
-
Selling general and administrative
18,918
18,137
17,134
15,413
13,209
-
Total operating expenses
88,955
83,936
87,672
89,954
62,984
-
Operating income or loss
-88,545
-83,510
-87,740
-85,544
-54,799
-
Interest expense
34
35
8
5
9.421
-
Total other income/expenses net
-12,284
-12,253
-32
-11,744
24.147
-
Income before tax
-92,767
-88,447
-84,910
-97,090
-54,462
-
Income tax expense
-
0
-197
0
-5,417
-
Income from continuing operations
-92,767
-88,447
-84,713
-97,090
-49,044
-
Net income
-92,767
-88,447
-84,713
-97,090
-49,044
-
Net income available to common shareholders
-92,767
-88,447
-84,713
-97,090
-49,044
-
Basic EPS
-1.54
-
-1.81
-2.35
-1.91
-1.60
Diluted EPS
-1.54
-
-1.81
-2.35
-1.91
-1.60
Basic average shares
51,137
-
46,926
41,283
25,637
13,125
Diluted average shares
51,137
-
46,926
41,283
25,637
13,125